TO THE EDITOR-Weinheimer et al [1] reported that influenza A viruses preferentially infect alveolar epithelial type II (ATII) cells in lung tissue explants and suggested that the pathogenicity of influenza A viruses is associated with the ability of these viruses to replicate in ATII cells and induce the production of inflammatory cytokines. In contrast, an epidemiological study by Nguyen-Van-Tam et al [2] demonstrated that chronic pulmonary comorbidities such as pulmonary fibrosis were risk factors for poor outcomes for 2009 pandemic influenza A virus subtype H1N1 (A[H1N1]pdm09) infection. Pulmonary fibrosis is a collective and clinicopathological term for a disease characterized by shortness of breath during exercise, abnormal lung physiology, reduced gas transfer, and excessive scar formation in the lung interstitium. Two studies using genome-wide RNA interference screening identified host factors that are required for the replication of influenza virus [3, 4] . These studies suggest that not only viral strains but also host factors associated with existing pulmonary diseases should be studied to gain a better understanding of the mechanisms of influenza A virus pathogenesis.
To our knowledge, there are no studies investigating whether influenza virus infection of ATII cells in diseased lungs is more severe than in normal lungs. On the basis of an epidemiological study [2] , we hypothesized that the infection of ATII cells with A(H1N1) pdm09 is more severe for cells from pulmonary fibrotic lungs than for cells from nonfibrotic lungs. To address this question, we infected ATII cells isolated from fibrotic lungs and nonfibrotic lungs with A(H1N1)pdm09 and then compared viral titers in the culture supernatants. This study was approved by the ethics committees of the Tohoku University School of Medicine and the Japanese Red Cross Ishinomaki Hospital. All patients gave their informed consent.
Nonfibrotic lung tissue specimens were obtained from 4 patients who underwent surgery because of lung cancer. The nonfibrotic tissue specimens were resected from portions distal to the cancerous lesions. A histopathological examination confirmed that these nonfibrotic lung tissues did not contain any lesions, including those associated with cancer, fibrosis, emphysema, or inflammatory changes (data not shown). Fibrotic lung tissue specimens were obtained from patients who underwent open lung biopsy or lung resection because of lung cancer. The clinical diagnoses based on pathological examinations of the fibrotic lesions included idiopathic pulmonary fibrosis (in 3 patients), cellular nonspecific interstitial pneumonia (in 1), and chronic hypersensitivity pneumonitis (in 1). We excluded patients in whom other respiratory disorders, such as asthma or chronic obstructive pulmonary disease, were diagnosed that might also be risk factors for poor outcomes for A(H1N1) pdm09 infection [5] . We also excluded patients who had been treated with chemotherapy before surgery. Statistical analysis was conducted using GraphPad Prism version 5.0d (GraphPad Software, La Jolla, CA). The Mann-Whitney U test was performed to evaluate statistical significance. A P value of <.05 was considered statistically significant. ATII cells were purified using a method that we recently established [6] . The freshly isolated ATII cells were cultured on recombinant human laminin-5 (Oriental Yeast, Tokyo, Japan) in Dulbecco's modified Eagle's medium (Life Technologies, Carlsbad, CA) containing 0.5% bovine serum albumin (Sigma-Aldrich, St. Louis, MO), penicillin, streptomycin, amphotericin B (Life Technologies), and human recombinant keratinocyte growth factor (10 ng/mL; PeproTech, Rocky Hill, NJ). After 24 hours, the ATII cells were infected with 0.5 multiplicity of infection of A(H1N1)pdm09 for 1 hour. We collected culture supernatant fluids 24 hours after addition of the influenza virus and quantified the viral titers in the culture supernatants as previously described [7] . We found that the viral titers for ATII cells isolated from fibrotic lungs were significantly higher than the titers for cells from nonfibrotic lungs (Figure 1 ).
Our data suggest that the infection of ATII cells is more extensive in fibrotic lungs than in normal lungs and support epidemiological data indicating that pulmonary fibrosis is a risk factor for poor outcomes of A(H1N1)pdm09 infection [2] . Moreover, our study highlights that host factors associated with the severity of influenza virus infection differ between ATII cells subjected to profibrotic conditions and those in normal niches. This result indicates that it is important to identify host factors related to preexisting disease because the identification of such factors might lead to the development of personalized medicine for the treatment of influenza virus infection.
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